BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Prognosis
7 results:

  • 1. dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.
    Zapanta Rinonos S; Li T; Pianka ST; Prins TJ; Eldred BSC; Kevan BM; Liau LM; Nghiemphu PL; Cloughesy TF; Lai A
    J Neurooncol; 2024 Jan; 166(1):129-142. PubMed ID: 38224404
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
    Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
    Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas.
    Sugur HS; Rao S; Sravya P; Athul Menon K; Arivazhagan A; Mehta B; Santosh V
    Pathol Res Pract; 2023 May; 245():154464. PubMed ID: 37116364
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling.
    Tu Y; Xu L; Xu J; Bao Z; Tian W; Ye Y; Sun G; Miao Z; Chao H; You Y; Liu N; Ji J
    Oncogene; 2022 Apr; 41(18):2597-2608. PubMed ID: 35332268
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. dnmt3a/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The cancer Genome Atlas.
    He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
    Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Importance of Mutational Drivers in GBM.
    Kalkan R
    Crit Rev Eukaryot Gene Expr; 2016; 26(1):19-26. PubMed ID: 27278882
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.